Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
British Journal of Haematology
|
July 20, 2006
Diagnosis of Burkitt lymphoma in due time: a practical approach
Sergio B Cogliatti, Urban Novak, Samuel Henz, et al.
Onkologie
|
October 16, 2008
CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study
Markus Joerger, Dominique F Nuessli, Samuel Henz, et al.
The Journal of Pathology
|
May 12, 2005
IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome
Sergio B Cogliatti, Francesco Bertoni, Dieter R Zimmermann, et al.
Swiss Medical Weekly
|
November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
Barbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 4, 2022
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
British Journal of Haematology
|
July 20, 2006
Diagnosis of Burkitt lymphoma in due time: a practical approach
Sergio B Cogliatti, Urban Novak, Samuel Henz, et al.
Onkologie
|
October 16, 2008
CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study
Markus Joerger, Dominique F Nuessli, Samuel Henz, et al.
The Journal of Pathology
|
May 12, 2005
IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome
Sergio B Cogliatti, Francesco Bertoni, Dieter R Zimmermann, et al.
Swiss Medical Weekly
|
November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
Barbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 4, 2022
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, et al.
Page
of 2